Are all intracranial mass lesions always a contraindication for thrombolytic therapy?

---

Gullupinar B., ÇOLAK N., Bayram B.

HONG KONG JOURNAL OF EMERGENCY MEDICINE, cilt.21, sa.2, ss.98-102, 2014 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 21 Sayı: 2
• Basım Tarihi: 2014
• Doi Numarası: 10.1177/102490791402100212
• Dergi Adı: HONG KONG JOURNAL OF EMERGENCY MEDICINE
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.98-102
• Anahtar Kelimeler: Adult, cardiogenic shock, meningioma, pulmonary embolism, treatment outcome
• Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
• Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Thrombolytic therapy, is regarded as the first treatment choice in haemodynamically unstable patients with pulmonary embolism. Intracranial tumors have long been considered as a contraindication to thrombolytic therapy due to the risk of intracerebral haemorrhage. In this report, we presented a 76-year-old female patient with meningioma and massive pulmonary embolism who had received thrombolytic therapy despite a contraindication of intracranial mass. The patient completed the thrombolytic therapy without having complication.